Pulsed Short Wave Therapy In Cesarean Section

Protocol For The Randomized Controlled Trial Of Pulsed Short Wave Therapy In Cesarean Section

This clinical study is designed to assesses the benefit of adding pulsed shortwave therapy to the postoperative pain and recovery protocol following Cesarean section. Pulsed shortwave therapy is a safe adjunct pain therapy for acute and chronic pain.

Pain is ranked highest among undesirable clinical outcomes associated with caesarean section therefore postoperative pain relief following a cesarean section is extremely important to optimize maternal and neonate well being. Multimodial analgesics are effective in reducing postoperative pain but analgesia is still not optimized. Opiate based analgesics are effective but having troubling side effects. Addition of non-drug pain therapies hold promise in improving postoperative recovery while potentially allowing for reduced use of drug based analgesics.

Inclusion Criteria:

• Voluntarily
• Performed using spinal anesthesia
• ASA I (Normal healthy patients) and II (Patients with mild systemic disease) (as defined by the American Society of Anesthesiologists Physical Status Classification system)
• PARA 0000, 1, 2, 3 [i.e. First, Second, or Third C-Section)
• At term pregnancy (>38 weeks)
• BMI <35
• Age between 18 - 50 years

Exclusion Criteria:

• Longitudinal surgical incision
• Placental abnormalities noted
• Time of extraction of the fetus >10 min from cutaneous incision
• Blood loss during surgery of >800 ml
• Any of the conditions not considered in inclusion criteria